These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7039239)

  • 1. Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring.
    Ahrén B; Scherstén B; Agardh CD; Lundquist I
    Acta Med Scand; 1981; 210(5):337-48. PubMed ID: 7039239
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment.
    Ahrén B; Lundquist I; Hedner P; Valdemarsson S; Scherstén B
    Diabetes Res; 1985 Mar; 2(2):95-103. PubMed ID: 2412749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
    Ahrén B; Lundquist I; Scherstén B
    Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylsalicylic acid augments insulin and C-peptide responses to arginine in diabetes mellitus.
    Giugliano D; Cacciapuoti F; Varricchio M
    Prostaglandins Med; 1979 Feb; 2(2):109-10. PubMed ID: 398985
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypoglycemia-induced inhibition of insulin secretion in metabolically healthy subjects, in diabetics and in patients with adrenalectomy].
    Krause U; Faisst G; Cordes U; Beyer J
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1391-3. PubMed ID: 611850
    [No Abstract]   [Full Text] [Related]  

  • 6. The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.
    Elkeles RS; Heding LG; Paisey RB
    Diabetes Care; 1982; 5(4):427-9. PubMed ID: 6759080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and C-peptide secretory responses to glucagon in man: studies on the dose-response relationships.
    Ahrén B; Nobin A; Scherstén B
    Acta Med Scand; 1987; 221(2):185-90. PubMed ID: 3296670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man.
    Goldsmith SJ; Yalow RS; Berson SA
    Diabetes; 1970 Jun; 19(6):453-7. PubMed ID: 4393032
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute insulin response to glucagon, tolbutamide, and glucose in non-insulin-dependent diabetes of the young.
    Naidoo C; Jialal I; Suleman A; Rajput MC; Joubert SM
    Diabetes Care; 1986; 9(1):57-60. PubMed ID: 3512209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate.
    Kanatsuka A; Makino H; Sakurada M; Hashimoto N; Iwaoka H; Yamaguchi T; Taira M; Yoshida S; Yoshida A
    Metabolism; 1988 Sep; 37(9):878-84. PubMed ID: 3047522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal.
    Pozzilli P; Raz I; Peled D; Elias D; Avron A; Tamir M; Eren R; Dagan S; Cohen IR
    Diabetes Care; 2014; 37(5):1384-91. PubMed ID: 24408401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide.
    Almér LO; Johansson E; Melander A; Wåhlin-Boll E
    Acta Med Scand Suppl; 1981; 656():11-8. PubMed ID: 7046346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
    Kruszynska YT; Ghatei MA; Bloom SR; McIntyre N
    Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human C-peptide in normal and diabetic subjects.
    Heding LG; Rasmussen SM
    Diabetologia; 1975 Jun; 11(3):201-6. PubMed ID: 1149953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell function.
    Seigler DE; Reeves ML; Skyler JS
    Diabetes Care; 1982; 5(3):334-6. PubMed ID: 6756843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.